West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance

West Pharmaceutical Services, Inc. (WST) reported third-quarter 2024 adjusted earnings per share (EPS) of $1.85, which beat the Zacks Consensus Estimate of$1.51 by 22.5%. However, the bottom line decreased 14.4% year over year.The adjustments include expenses related to the amortization of acquisition-related intangible assets.GAAP EPS for the quarter was $1.85, down 13.6% year over year.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Revenues in DetailWest Pharmaceutical registere ...